BIO-RAD LAB-A (BUWA BE) stock market data APIs
€235.3752
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
BIO-RAD LAB-A Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BUWA.BE.
Prev. Close
235.3752
Open
235.3752
High
235.3752
Low
235.3752
52 wk Range
187.6-351.8
Market Cap
19 783 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BIO-RAD LAB-A data using free add-ons & libraries
Get BIO-RAD LAB-A Fundamental Data
BIO-RAD LAB-A Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIO-RAD LAB-A News
New
Alger Russell Innovation Index Updates for Third Quarter 2025
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovat...
When Should You Buy Bio-Rad Laboratories, Inc. (NYSE:BIO)?
Bio-Rad Laboratories, Inc. (NYSE:BIO), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the NYSE over the last few months. While good news for sh...
Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery?
Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund underperformed and generated a net r...
Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?
Bio-Rad Laboratories, Inc. BIO is well-poised to grow in the upcoming quarters, courtesy of its strong traction in the QX600 Droplet Digital PCR (ddPCR) platform. Demand for its quality control and im...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
